Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 818 | 16.51 |
09:34 ET | 100 | 16.75 |
10:15 ET | 1193 | 16.36 |
10:17 ET | 1257 | 16.36 |
10:19 ET | 100 | 16.18 |
10:24 ET | 695 | 16.3313 |
10:35 ET | 153 | 16.5 |
10:46 ET | 505 | 16.245 |
10:48 ET | 200 | 16.3 |
10:57 ET | 250 | 16.256 |
11:02 ET | 107 | 16.2749 |
11:13 ET | 133 | 16.31 |
11:15 ET | 100 | 16.32 |
11:42 ET | 100 | 16.47 |
12:27 ET | 420 | 16.14 |
12:30 ET | 185 | 16.1643 |
12:36 ET | 100 | 16.26 |
12:48 ET | 200 | 16.15 |
12:54 ET | 800 | 16.24 |
12:56 ET | 6073 | 16.24 |
12:57 ET | 3924 | 16.28 |
12:59 ET | 7175 | 16.31 |
01:01 ET | 1200 | 16.3 |
01:06 ET | 200 | 16.32 |
01:08 ET | 2490 | 16.33 |
01:30 ET | 12216 | 16.1 |
01:32 ET | 300 | 16.11 |
01:42 ET | 200 | 16.04 |
01:44 ET | 577 | 16.03 |
01:51 ET | 300 | 16.05 |
02:18 ET | 597 | 16.0411 |
02:24 ET | 600 | 16.14 |
02:26 ET | 100 | 16.2 |
02:27 ET | 1000 | 16.16 |
02:40 ET | 100 | 16.17 |
02:49 ET | 100 | 16.08 |
02:51 ET | 2318 | 16.09 |
03:02 ET | 1200 | 16.08 |
03:05 ET | 6164 | 16.08 |
03:14 ET | 100 | 15.99 |
03:16 ET | 200 | 16.005 |
03:18 ET | 2250 | 16.015 |
03:25 ET | 120 | 16.09 |
03:32 ET | 430 | 16.04 |
03:36 ET | 200 | 16.06 |
03:45 ET | 302 | 16.13 |
03:48 ET | 496 | 16.115 |
03:50 ET | 200 | 16.12 |
03:54 ET | 600 | 16.17 |
03:57 ET | 437 | 16.14 |
03:59 ET | 19505 | 16.1 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 1.0B | -20.3x | --- |
Nano-X Imaging Ltd | 347.5M | -6.3x | --- |
Atlantic International Corp | 268.0M | -0.6x | --- |
Simulations Plus Inc | 617.2M | 63.8x | +3.18% |
IRadimed Corp | 628.0M | 33.6x | +21.02% |
Orchestra Biomed Holdings Inc | 186.9M | -3.1x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 61.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.76 |
EPS | $-0.79 |
Book Value | $0.80 |
P/E Ratio | -20.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.